What is Travere Therapeutics, Inc.'s capex?

Travere Therapeutics, Inc. (TVTX) reported capex of $140K in Q3 2025.

What is the long-term trend for Travere Therapeutics, Inc.'s capex?

Over 2 years (2021 to 2023), Travere Therapeutics, Inc.'s capex has grown at a -63.8% compound annual growth rate (CAGR), from $5.1M to $668K.

What does capex mean?

Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

Travere Therapeutics, Inc. TVTX CapEx

Discontinued — last reported Q3 '25

CapEx at other companies

Vertex PharmaceuticalsVRTX

$133.4M+228%

LQD

Liquidia CorporationLQDA

$2.83M+758%

BridgeBio PharmaBBIO

$69K—

PTC TherapeuticsPTCT

$1.2M-30.6%

Catalyst PharmaceuticalCPRX

$27K—

Acadia PharmaceuticalsACAD

$5.21M—

Other financials

Income statement

See full

Revenue$127.2M+55.6%

Gross profit$125.2M+62.5%

Operating income-$36.9M+13.5%

Net income-$37.1M+10.0%

EPS (diluted)-$0.40+14.9%

Balance sheet

See full

Cash & equivalents$78.4M+26.6%

Total debt$15.6M-82.6%

Total equity$98.7M+201%

Total assets$555.2M+1.2%

Cash flow

See full

Operating cash flow-$40.4M+4.3%

Free cash flow-$42.5M+28.1%

Valuation

See full

Market cap$5.13B+72.3%

Profitability

See full

Gross margin98.6%+2.6pp

Operating margin-10.6%-5.0pp

Net margin-20.3%-9.5pp

FCF margin-133.9%-34.4pp

Returns & leverage

See full

Return on equity-706%-1,302pp

Debt / equity0.2×-2.6×

Current ratio3.1×+1.1×

Where this comes from

Reported directly by Travere Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Travere Therapeutics, Inc.’s 10-Q, filed October 30, 2025, on SEC EDGAR. View the filing →

Ask your AI about Travere Therapeutics, Inc.'s capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Travere Therapeutics, Inc.'s capex?: Travere Therapeutics, Inc. (TVTX) reported capex of $140K in Q3 2025.
What is the long-term trend for Travere Therapeutics, Inc.'s capex?: Over 2 years (2021 to 2023), Travere Therapeutics, Inc.'s capex has grown at a -63.8% compound annual growth rate (CAGR), from $5.1M to $668K.
What does capex mean?: Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.